stock price
Nautilus Biotechnology Receives Delisting Notice From Nasdaq
The company has until late October to regain compliance with the stock exchange's $1 per share minimum bid price requirement.
GenomeWeb Top 40 Falls 5 Percent in April Amidst Mixed Broader Market
The Dow Jones Industrial Average fell 3 percent while the Nasdaq and the Nasdaq Biotech Index each rose by less than 1 percent.
GenomeWeb Top 40 Pops 10 Percent After Tariff Pause; Still Down 3 Percent Since Tariffs Introduced
Premium
Shares of every company in the Top 40 rose on the news that Trump is pausing most of the reciprocal tariffs he announced at the beginning of the month.
GenomeWeb Top 40 Falls 6 Percent in March, Tracking Decline in Broader Market
The Dow Jones Industrial Average fell 4 percent while the Nasdaq fell 8 percent and the Nasdaq Biotech Index declined by 6 percent.
GenomeWeb Top 40 Plummets 14 Percent in February as Government Spending Concerns Loom
The Dow Jones Industrial Average fell 2 percent, the Nasdaq fell 4 percent, and the Nasdaq Biotech Index declined by less than 1 percent.
Feb 10, 2025
Barclays Downgrades Illumina to Underweight
Feb 5, 2025
GeneDx Shares Fall on Short Seller Report
Jan 10, 2025
Quanterix to Acquire Akoya Biosciences
Nov 25, 2024